B

Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC

Watchlist Manager
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Watchlist
Price: 3.01 USD -57.3% Market Closed
Market Cap: 58m USD

Bellevue Life Sciences Acquisition Corp
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Bellevue Life Sciences Acquisition Corp
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
B
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WP Carey Inc
NYSE:WPC
EPS (Diluted)
$1
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
1%
Starwood Property Trust Inc
NYSE:STWD
EPS (Diluted)
$0
CAGR 3-Years
-35%
CAGR 5-Years
-6%
CAGR 10-Years
-6%
Annaly Capital Management Inc
NYSE:NLY
EPS (Diluted)
$2
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ares Capital Corp
NASDAQ:ARCC
EPS (Diluted)
$1
CAGR 3-Years
8%
CAGR 5-Years
21%
CAGR 10-Years
2%
SoFi Technologies Inc
NASDAQ:SOFI
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bellevue Life Sciences Acquisition Corp
Glance View

Market Cap
58m USD
Industry
N/A

Bellevue Life Sciences Acquisition Corp. operates as a blank check company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The firm has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm may pursue an acquisition opportunity in any business industry or sector. The firm intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The firm neither engaged in any operations nor generated any revenues.

BLAC Intrinsic Value
Not Available
B

See Also

What is Bellevue Life Sciences Acquisition Corp's EPS (Diluted)?
EPS (Diluted)
0.1 USD

Based on the financial report for Dec 31, 2023, Bellevue Life Sciences Acquisition Corp's EPS (Diluted) amounts to 0.1 USD.

Back to Top